3 results
Main: To evaluate the safety and effectiveness of the Exhale Drug-Eluting Stent (DES) to improve pulmonary function for homogeneous emphysema subjects with severe hyperinflation, in a prospective, randomized, Sham-controlled, double-blind, multi-…
In this study, we hypothesize that the reference product (SalbR/Ventolin) is more effective than SalbG (Salbutamol Sandoz) atimproving the lungfunction in children with asthma, and that this difference increases alongside the severity of the airway…
To demonstrate that lorlatinib as a single agent (Arm A) is superior to crizotinib alone (Arm B) in prolonging Progression-Free Survival (PFS) in advanced ALK-positive NSCLC participants who are treatment naive.